Understanding how breast cancer spreads to the brain
Official title: Evaluation of Brain Metastasis Development Mechanism in Patients With Breast Cancer With Brain Metastasis(BCBM)
Run by Samsung Medical Center · NCT06330870 · Data updated 2026-11-12
This study is trying to understand how breast cancer spreads to the brain in patients who have had surgery for brain tumors, to help find better treatments.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | Women only |
| Enrollment | 30 (estimated) |
| Sponsor | Samsung Medical Center Academic / other |
| Locations | 1 site (Seoul) |
| Status | Recruiting |
| Started | April 6, 2023 |
| Main results expected | February 5, 2025 |
| Study ends | December 31, 2027 |
| Registry record updated | March 26, 2024 |
| Trial ID | NCT06330870 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients with breast cancer who have undergone curative surgery for brain metastasis.
✕Probably not a fit
Patients who have undergone Gamma Knife surgery will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the mechanisms behind the development of brain metastasis in patients diagnosed with breast cancer. It focuses on patients who have undergone curative surgery for brain metastasis and utilizes whole genome sequencing and tumor microenvironment evaluation as its primary interventions. The goal is to uncover biological factors that contribute to the spread of breast cancer to the brain, which could lead to improved treatment strategies.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and treatment options for breast cancer patients with brain metastasis.
How similar studies have gone: While there may be studies exploring similar mechanisms, this specific approach focusing on breast cancer brain metastasis is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Breast cancer * Brain metastasis curative surgery patient Exclusion Criteria: * Gamma Knife surgery patient
Where it's running
-
Ji-Yeon Kim
Seoul, South Korea Recruiting
Study contacts
- Study coordinator: Ji-Yeon Kim
- Email: jyeon25@skku.edu
- Phone: 82-2-3410-3459
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.